Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  BioMarin Pharmaceutical Inc.    BMRN   US09061G1013

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
03/20/2015 03/23/2015 03/24/2015 03/25/2015 03/26/2015 Date
125.17(c) 123.62(c) 123(c) 115.62(c) 115.55(c) Last
2 290 756 1 802 317 1 579 093 2 544 753 2 241 156 Volume
-1.82% -1.24% -0.50% -6.00% -0.06% Change
More quotes
Financials ($)
Sales 2015 870 M
EBIT 2015 -326 M
Net income 2015 -348 M
Debt 2015 172 M
Yield 2015 -
Sales 2016 1 105 M
EBIT 2016 -148 M
Net income 2016 -171 M
Debt 2016 179 M
Yield 2016 -
PER 2015 -
PER 2016
EV / Sales 2015 21,3x
EV / Sales 2016 16,8x
Capitalization 18 399 M
More Financials
Company
BioMarin Pharmaceutical, Inc. develops and commercializes innovative pharmaceuticals for serious diseases and medical conditions.The company operates its business through one segment, the biopharmaceutical development and commercialization segment.Its company's product portfolio is comprised of... 
Sector
Pharmaceuticals
Calendar
04/30Earnings Release
More about the company
Surperformance© ratings of BioMarin Pharmaceutical In
Trading Rating : Investor Rating :
More Ratings
Latest news on BIOMARIN PHARMACEUTICAL IN
03/18 BIOMARIN PHARMACEUTICAL : Reports Inducement Grants Under NASDAQ Listing Rule 56..
03/18 BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing R..
03/17 MYRIAD GENETICS : and BioMarin Expand Collaboration to Evaluate myChoice HRD(TM)..
03/11 BIOMARIN PHARMACEUTICAL : Investigators from BioMarin Pharmaceutical Zero in on ..
03/06 BIOMARIN PHARMACEUTICAL : Change in Directors or Principal Officers (form 8-K)
03/05 BIOMARIN PHARMACEUTICAL : BMRN) is Trading Higher on Unusual Volume for March 05
02/25 BIOMARIN PHARMACEUTICAL : reports 4Q loss
02/25 BIOMARIN PHARMACEUTICAL : Results of Operations and Financial Condition, Financi..
More news
Sector news : Generic Pharmaceuticals
01:10a U.S. biotech stocks may fall further as short interest rises
03/26 ROCHE BEARER SHARE : Drug manufacturer Genentech to expand Hillsboro operations
03/26 CELGENE : MorphoSys And Celgene Agree To End MOR202 Collaboration
More sector news : Generic Pharmaceuticals
News from SeekingAlpha
03/26 PHARMACYCLICS, BIOMARIN, AND INCYTE : A Quick Screen
03/17 Myriad and BioMarin expand collaboration
03/17 Not Discounting Good News Is Creating Opportunities - Cramer's Mad Money (3/1..
03/16 BIOMARIN : Expect First-Pass Drisapersen Approval
03/13 MasterCard Is At A Discount - Cramer's Lightning Round (3/12/15)


Comments 
Advertisement
Chart BIOMARIN PHARMACEUTICAL IN
Duration : Period :
BioMarin Pharmaceutical In Technical Analysis Chart | BMRN | US09061G1013 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF